Breaking News

  • 57 minutes ago

  • Pharma Now Editorial Team

Novartis Gains EU Conditional Approval for Vijoice in Rare PIK3CA-Related Overgrowth Disorder PROS
Breaking News

More News

Ionetix Gains First ANDA Approval for Ga-68 Gozetotide, Expanding Multi-Site PET Network

Ionetix Gains First ANDA Approval for Ga-68 Gozetotide, Expanding Mult...

Pharma Now Editorial Team

60 Degrees Pharmaceuticals Achieves Early Enrollment Milestone in Tafenoquine Babesiosis Trial

60 Degrees Pharmaceuticals Achieves Early Enrollment Milestone in Tafe...

Pharma Now Editorial Team

Boehringer Ingelheim Gains China Approval for HERNEXEOS in Unresectable NSCLC

Boehringer Ingelheim Gains China Approval for HERNEXEOS in Unresectabl...

Pharma Now Editorial Team

Novo Nordisk POSEIDON Study Finds CV Inflammation in 2 in 5 High-Risk Patients Globally

Novo Nordisk POSEIDON Study Finds CV Inflammation in 2 in 5 High-Risk ...

Pharma Now Editorial Team

Ad
Advertisement

Interviews & Opinions

Article

“If You Want to Be a King, First Behave Like One” Naresh Kumar Gaur on Leadership & Ownership

Naresh Kumar Gaur says pharma titles follow behaviour, not the other way around. Why most professionals are waiting for a crown they have to earn firs...

FT - Mr. Naresh Kumar Gaur

Read More

Article
From ‘Why Reject?’ to ‘How Release?’: Deepak Kasbi on the Cultural Shift in Pharma Quality

FT - Mr. Deepak Kasbi

Article
Five Pillars Of Leadership That Built A Pharma Veteran: Shyam Khante’s 45-Year Pharma Journey

FT - Mr. Shyam Khante

Article
“Quality is Driven by Science” – Leadership Lessons from Zydus President Vikram Shukla

FT - Mr. Vikram Shukla

Ad
Advertisement
Ad